G01N 2333/70582
Cd71
G01N2333/70582 (Cd71) appears on 24 US grants and 51 published applications in this corpus.
Search patents in G01N- Granted patents
- 24
- Published applications
- 51
- Assignees
- 32
- Inventors
- 96
- Latest grant
- 3 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 3 |
| 2007 | 0 | 6 |
| 2008 | 1 | 2 |
| 2009 | 0 | 0 |
| 2010 | 2 | 0 |
| 2011 | 3 | 3 |
| 2012 | 1 | 2 |
| 2013 | 3 | 1 |
| 2014 | 2 | 3 |
| 2015 | 2 | 2 |
| 2016 | 2 | 4 |
| 2017 | 0 | 2 |
| 2018 | 1 | 2 |
| 2019 | 0 | 3 |
| 2020 | 0 | 1 |
| 2021 | 2 | 1 |
| 2022 | 2 | 3 |
| 2023 | 1 | 3 |
| 2024 | 0 | 2 |
| 2025 | 0 | 1 |
| 2026 | 1 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Flow cytometry system and methods for the diagnosis of infectious disease3 Mar 2026US 12,566,176 B2FlowMetric Life Sciences, Inc.
- Human bladder cancer marker AG-CD71 and antibody ABC71 and application thereof14 Feb 2023US 11,578,134 B2
- Flow cytometry system and methods for the diagnosis of infectious disease29 Nov 2022US 11,513,119 B2FlowMetric Life Sciences, Inc.
- RNA aptamers against transferrin receptor (TFR)1 Feb 2022US 11,236,341 B2Apterna Ltd
- Microfluidic device for cell separation and uses thereof6 Jul 2021US 11,052,392 B2The General Hospital Corporation
- Model for analyzing inflammation and uses thereof10 Sep 2026US 2026/0266804 A1Technion Research & Development Foundation Limited
- Anti-tfr1 single-domain antibody and use thereof30 Jul 2026US 2026/0217847 A1Nanjing Regenecore Biotech Co., Ltd.
- Flow Cytometry System and Methods for the Diagnosis of Infectious Disease9 Jul 2026US 2026/0194521 A1FlowMetric Life Sciences, Inc.
- Cd71 binding fibronectin type iii domains4 Jun 2026US 2026/0151494 A1ARO Biotherapeutics Company
- Transferrin receptor binding proteins for treating brain tumors19 Feb 2026US 2026/0049155 A1Janssen Biotech, Inc.
Most cited
By later US patents
- Microfluidic device for cell separation and uses thereof147US 8,304,230 B2The General Hospital Corporation · 2012
- Microfluidic device for cell separation and uses thereof111US 8,372,579 B2The General Hospital Corporation · 2013
- Monoclonal antibodies with specificity for fetal erythroid cells80US 7,858,757 B2AdnaGen AG · 2010
- Method for the enumeration of micronucleated erythrocyte populations while distinguishing platelets and/or platelet-associated aggregates43US 7,425,421 B2Litron Laboratories, Ltd. · 2008
- Microfluidic device for cell separation and uses thereof39US 8,986,966 B2The General Hospital Corporation · 2015